Aggressive surgery for advanced ovarian cancer performed by a multidisciplinary team: A retrospective analysis on a large series of patients
AbstractBackgroundTo evaluate the impact of extended surgical treatment performed by a team of gynecologists and general surgeons on postoperative morbidity and survival of patients with advanced ovarian cancer. MethodsWe collected data of 156 patients with advanced ovarian cancer stage IIb-III-IV a...
Saved in:
| Published in: | Surgery open science Vol. 1; no. 1; pp. 43 - 47 |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
Elsevier Inc
01.07.2019
Elsevier |
| Subjects: | |
| ISSN: | 2589-8450, 2589-8450 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | AbstractBackgroundTo evaluate the impact of extended surgical treatment performed by a team of gynecologists and general surgeons on postoperative morbidity and survival of patients with advanced ovarian cancer. MethodsWe collected data of 156 patients with advanced ovarian cancer stage IIb-III-IV according to International Federation of Gynecology and Obstetrics classification and treated with primary cytoreduction. End points were perioperative and postoperative complications and cancer-related survival. ResultsIn 51 cases (51/156, 32.7%) a multivisceral resection was completed. Postoperative complications occurred in 52 cases (33.3%). The duration of the surgical procedure as well as the need for diaphragmatic peritonectomy were the factors independently associated with the development of postoperative complications. Five-year cancer-related survival rate was of 50.7%: only histotype and residual tumor resulted significantly associated. ConclusionsOur results highlight the importance of a team of gynecologists and general surgeons with specific interests and skills to achieve cytoreduction as rapidly as possible, even when it implies very complex maneuvers. |
|---|---|
| AbstractList | AbstractBackgroundTo evaluate the impact of extended surgical treatment performed by a team of gynecologists and general surgeons on postoperative morbidity and survival of patients with advanced ovarian cancer. MethodsWe collected data of 156 patients with advanced ovarian cancer stage IIb-III-IV according to International Federation of Gynecology and Obstetrics classification and treated with primary cytoreduction. End points were perioperative and postoperative complications and cancer-related survival. ResultsIn 51 cases (51/156, 32.7%) a multivisceral resection was completed. Postoperative complications occurred in 52 cases (33.3%). The duration of the surgical procedure as well as the need for diaphragmatic peritonectomy were the factors independently associated with the development of postoperative complications. Five-year cancer-related survival rate was of 50.7%: only histotype and residual tumor resulted significantly associated. ConclusionsOur results highlight the importance of a team of gynecologists and general surgeons with specific interests and skills to achieve cytoreduction as rapidly as possible, even when it implies very complex maneuvers. Background: To evaluate the impact of extended surgical treatment performed by a team of gynecologists and general surgeons on postoperative morbidity and survival of patients with advanced ovarian cancer. Methods: We collected data of 156 patients with advanced ovarian cancer stage IIb-III-IV according to International Federation of Gynecology and Obstetrics classification and treated with primary cytoreduction. End points were perioperative and postoperative complications and cancer-related survival. Results: In 51 cases (51/156, 32.7%) a multivisceral resection was completed. Postoperative complications occurred in 52 cases (33.3%). The duration of the surgical procedure as well as the need for diaphragmatic peritonectomy were the factors independently associated with the development of postoperative complications. Five-year cancer-related survival rate was of 50.7%: only histotype and residual tumor resulted significantly associated. Conclusions: Our results highlight the importance of a team of gynecologists and general surgeons with specific interests and skills to achieve cytoreduction as rapidly as possible, even when it implies very complex maneuvers. To evaluate the impact of extended surgical treatment performed by a team of gynecologists and general surgeons on postoperative morbidity and survival of patients with advanced ovarian cancer. We collected data of 156 patients with advanced ovarian cancer stage IIb-III-IV according to International Federation of Gynecology and Obstetrics classification and treated with primary cytoreduction. End points were perioperative and postoperative complications and cancer-related survival. In 51 cases (51/156, 32.7%) a multivisceral resection was completed. Postoperative complications occurred in 52 cases (33.3%). The duration of the surgical procedure as well as the need for diaphragmatic peritonectomy were the factors independently associated with the development of postoperative complications. Five-year cancer-related survival rate was of 50.7%: only histotype and residual tumor resulted significantly associated. Our results highlight the importance of a team of gynecologists and general surgeons with specific interests and skills to achieve cytoreduction as rapidly as possible, even when it implies very complex maneuvers. To evaluate the impact of extended surgical treatment performed by a team of gynecologists and general surgeons on postoperative morbidity and survival of patients with advanced ovarian cancer.BACKGROUNDTo evaluate the impact of extended surgical treatment performed by a team of gynecologists and general surgeons on postoperative morbidity and survival of patients with advanced ovarian cancer.We collected data of 156 patients with advanced ovarian cancer stage IIb-III-IV according to International Federation of Gynecology and Obstetrics classification and treated with primary cytoreduction. End points were perioperative and postoperative complications and cancer-related survival.METHODSWe collected data of 156 patients with advanced ovarian cancer stage IIb-III-IV according to International Federation of Gynecology and Obstetrics classification and treated with primary cytoreduction. End points were perioperative and postoperative complications and cancer-related survival.In 51 cases (51/156, 32.7%) a multivisceral resection was completed. Postoperative complications occurred in 52 cases (33.3%). The duration of the surgical procedure as well as the need for diaphragmatic peritonectomy were the factors independently associated with the development of postoperative complications. Five-year cancer-related survival rate was of 50.7%: only histotype and residual tumor resulted significantly associated.RESULTSIn 51 cases (51/156, 32.7%) a multivisceral resection was completed. Postoperative complications occurred in 52 cases (33.3%). The duration of the surgical procedure as well as the need for diaphragmatic peritonectomy were the factors independently associated with the development of postoperative complications. Five-year cancer-related survival rate was of 50.7%: only histotype and residual tumor resulted significantly associated.Our results highlight the importance of a team of gynecologists and general surgeons with specific interests and skills to achieve cytoreduction as rapidly as possible, even when it implies very complex maneuvers.CONCLUSIONSOur results highlight the importance of a team of gynecologists and general surgeons with specific interests and skills to achieve cytoreduction as rapidly as possible, even when it implies very complex maneuvers. |
| Author | Rausei, Stefano Boni, Luigi D'Alessandro, Valentina Uccella, Stefano Lianos, Georgios Rovera, Francesca Dionigi, Gianlorenzo Gisone, Baldo Ghezzi, Fabio Frattini, Francesco |
| Author_xml | – sequence: 1 fullname: Rausei, Stefano – sequence: 2 fullname: Uccella, Stefano – sequence: 3 fullname: D'Alessandro, Valentina – sequence: 4 fullname: Gisone, Baldo – sequence: 5 fullname: Frattini, Francesco – sequence: 6 fullname: Lianos, Georgios – sequence: 7 fullname: Rovera, Francesca – sequence: 8 fullname: Boni, Luigi – sequence: 9 fullname: Dionigi, Gianlorenzo – sequence: 10 fullname: Ghezzi, Fabio |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32754692$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFks9u1DAQxiNUREvpEyAhH7nsYsf2JkaiUlXxp1IlDsDZmtiTxUs2Dnay0r5DH5pJt0VtD3BK4pnvG-eb38viqI89FsVrwZeCi9W7zTLHAftlyYVZcr3kXD8rTkpdm0WtND968H5cnOW84ZyXlVFcqhfFsSwrrVamPCluLtbrhDmHHbI8pTWmPWtjYuB30Dv0LO4gBeiZmz8TGzBReUuFZs-AbaduDD5kF4Yu9EDiEWH7nl2whGOKeUA3ztbQQ7fPIbPYk6oDGsQypoB00rIBxoD9mF8Vz1voMp7dPU-LH58-fr_8srj--vnq8uJ64XTNx4VyleFNaQzwFqQRSnoB1arVXrZaVFRZmVrXaJxXUiB4r6VvhGphpUrwrTwtrg6-PsLGDils6eY2QrC3BzGtLaQxuA5t45E3AApboZXXAE5oWfkaK6xlDYa8zg9ew9RQLI7-I0H3yPRxpQ8_7TrubEU3r40ig7d3Bin-njCPdkt5YtdBj3HKtlSSryrBtaTWNw9n_R1yv05qMIcGR9nnhK11YaRw4zw6dFZwO9NjN_aWHjvTY7m2RA9p5RPtvf2_VR8OKqR97QImSyzgTE5ItHsKNPxHf_5E7wik4KD7hXvMmzglQidbYXNpuf02Uz1DLYzkXJRc_gGX2_is |
| CitedBy_id | crossref_primary_10_1016_j_ygyno_2023_10_021 crossref_primary_10_1136_ijgc_2021_003129 crossref_primary_10_1002_ijgo_14937 crossref_primary_10_2147_IDR_S399666 crossref_primary_10_1186_s13048_025_01624_3 crossref_primary_10_1245_s10434_020_09494_3 crossref_primary_10_3390_medicina61040695 crossref_primary_10_3390_cancers14174181 crossref_primary_10_1245_s10434_023_14423_1 crossref_primary_10_3390_cancers15010299 |
| Cites_doi | 10.1016/j.ygyno.2015.11.009 10.1016/j.ygyno.2015.12.007 10.1016/j.ajog.2007.10.495 10.1007/s00464-017-5899-9 10.1016/j.ygyno.2015.05.034 10.1245/s10434-017-6079-9 10.1136/ijgc-00009577-200409000-00006 10.1111/j.1471-0528.1989.tb03341.x 10.1097/01.AOG.0000192407.04428.bb 10.1016/j.ygyno.2009.03.018 10.1016/j.ajog.2008.06.052 10.1056/NEJMoa0908806 10.1245/s10434-010-0964-9 10.1016/S0140-6736(14)62223-6 10.1097/SLA.0b013e3181b13ca2 10.1002/cncr.24149 10.1097/AOG.0b013e31819cda77 10.1016/j.ygyno.2018.07.004 10.1136/ijgc-00009577-200511000-00003 10.3802/jgo.2015.26.4.336 10.1016/j.ygyno.2017.07.136 10.1016/j.ygyno.2018.03.044 10.1200/JCO.2002.20.5.1248 |
| ContentType | Journal Article |
| Copyright | The Authors 2019 The Authors 2019 The Authors. 2019 The Authors 2019 |
| Copyright_xml | – notice: The Authors – notice: 2019 The Authors – notice: 2019 The Authors. – notice: 2019 The Authors 2019 |
| DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.1016/j.sopen.2019.05.005 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 2589-8450 |
| EndPage | 47 |
| ExternalDocumentID | oai_doaj_org_article_bde0baa4ef154d5aac1537d8e7e838a9 PMC7391894 32754692 10_1016_j_sopen_2019_05_005 S2589845019300120 1_s2_0_S2589845019300120 |
| Genre | Journal Article |
| GroupedDBID | 0R~ 53G AAEDW AALRI AAXUO AAYWO ACVFH ADCNI ADVLN AEUPX AEXQZ AFJKZ AFPUW AIGII AITUG AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP EBS FDB GROUPED_DOAJ M41 M~E OK1 ROL RPM SSZ 0SF 6I. AAFTH NCXOZ .1- .FO AAYXX AFRHN AJUYK CITATION Z5R NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c580t-4c790b299a0fa39143d1a76f5d3f517b2969858e9cd431eadd53db14fa642adf3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 14 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000693660100009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2589-8450 |
| IngestDate | Tue Oct 14 18:13:49 EDT 2025 Tue Nov 04 01:56:36 EST 2025 Thu Jul 10 18:55:04 EDT 2025 Thu Jan 02 22:54:36 EST 2025 Thu Nov 13 04:34:16 EST 2025 Tue Nov 18 21:26:03 EST 2025 Fri Feb 23 02:47:11 EST 2024 Sat Sep 27 20:31:59 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | This is an open access article under the CC BY license. 2019 The Authors. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c580t-4c790b299a0fa39143d1a76f5d3f517b2969858e9cd431eadd53db14fa642adf3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://doaj.org/article/bde0baa4ef154d5aac1537d8e7e838a9 |
| PMID | 32754692 |
| PQID | 2430671053 |
| PQPubID | 23479 |
| PageCount | 5 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_bde0baa4ef154d5aac1537d8e7e838a9 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7391894 proquest_miscellaneous_2430671053 pubmed_primary_32754692 crossref_citationtrail_10_1016_j_sopen_2019_05_005 crossref_primary_10_1016_j_sopen_2019_05_005 elsevier_sciencedirect_doi_10_1016_j_sopen_2019_05_005 elsevier_clinicalkeyesjournals_1_s2_0_S2589845019300120 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-07-01 |
| PublicationDateYYYYMMDD | 2019-07-01 |
| PublicationDate_xml | – month: 07 year: 2019 text: 2019-07-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Surgery open science |
| PublicationTitleAlternate | Surg Open Sci |
| PublicationYear | 2019 |
| Publisher | Elsevier Inc Elsevier |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier |
| References | Clavien, Barkun, de Oliveira (bb0085) 2009; 250 Kotsopoulos, Rosen, Fan (bb0010) 2016; 140 Chi, Eisenhauer, Zivanovic (bb0055) 2009; 114 Shepherd (bb0075) 1989; 96 Suidan, Leitao, Zivanovic (bb0120) 2015; 138 Timmermans, van der Aa, Lalisang (bb0115) 2018; 150 Kehoe, Hook, Nankivell (bb0065) 2015; 386 Wimberger, Wehling, Lehmann (bb0005) 2010; 17 Chang, Bristow, Chi, Cliby (bb0045) 2015; 26 Partridge, Kreimer, Greenlee (bb0090) 2009; 113 Vergote, Trope, Amant (bb0060) 2010; 363 Aletti, Dowdy, Gostout (bb0035) 2006; 107 Rubin, Randall, Armstrong (bb0030) 1999; 93 Ceccaroni, Roviglione, Bruni, Clarizia, Ruffo, Salgarello (bb0070) 2018; 32 Tate, Kato, Nishikimi, Matsuoka (bb0095) 2017; 147 Du Bois, Reuss, Pujade-Lauraine (bb0020) 2009; 115 Uccella, Mele, Quagliozzi (bb0100) 2018; 149 Kaern, Aghmesheh, Nesland (bb0025) 2005; 15 Bristow, Tomacruz, Armstrong (bb0050) 2002; 20 Aletti, Dowdy, Podratz, Cliby (bb0110) 2007; 197 Fagotti, Ferrandina, Fanfani (bb0080) 2008; 199 Kahl, du Bois, Harter (bb0105) 2017; 24 Ataseven, Grimm, Hater (bb0040) 2016; 140 Lambert, Gregory, Nelstrop, Rustin (bb0015) 2004; 14 Ceccaroni (10.1016/j.sopen.2019.05.005_bb0070) 2018; 32 Lambert (10.1016/j.sopen.2019.05.005_bb0015) 2004; 14 Partridge (10.1016/j.sopen.2019.05.005_bb0090) 2009; 113 Aletti (10.1016/j.sopen.2019.05.005_bb0110) 2007; 197 Clavien (10.1016/j.sopen.2019.05.005_bb0085) 2009; 250 Suidan (10.1016/j.sopen.2019.05.005_bb0120) 2015; 138 Tate (10.1016/j.sopen.2019.05.005_bb0095) 2017; 147 Aletti (10.1016/j.sopen.2019.05.005_bb0035) 2006; 107 Kehoe (10.1016/j.sopen.2019.05.005_bb0065) 2015; 386 Uccella (10.1016/j.sopen.2019.05.005_bb0100) 2018; 149 Wimberger (10.1016/j.sopen.2019.05.005_bb0005) 2010; 17 Vergote (10.1016/j.sopen.2019.05.005_bb0060) 2010; 363 Du Bois (10.1016/j.sopen.2019.05.005_bb0020) 2009; 115 Chi (10.1016/j.sopen.2019.05.005_bb0055) 2009; 114 Kaern (10.1016/j.sopen.2019.05.005_bb0025) 2005; 15 Shepherd (10.1016/j.sopen.2019.05.005_bb0075) 1989; 96 Kotsopoulos (10.1016/j.sopen.2019.05.005_bb0010) 2016; 140 Timmermans (10.1016/j.sopen.2019.05.005_bb0115) 2018; 150 Fagotti (10.1016/j.sopen.2019.05.005_bb0080) 2008; 199 Ataseven (10.1016/j.sopen.2019.05.005_bb0040) 2016; 140 Kahl (10.1016/j.sopen.2019.05.005_bb0105) 2017; 24 Bristow (10.1016/j.sopen.2019.05.005_bb0050) 2002; 20 Rubin (10.1016/j.sopen.2019.05.005_bb0030) 1999; 93 Chang (10.1016/j.sopen.2019.05.005_bb0045) 2015; 26 |
| References_xml | – volume: 250 start-page: 187 year: 2009 end-page: 196 ident: bb0085 article-title: The Clavien-Dindo classification of surgical complications: five-year experience publication-title: Ann Surg – volume: 138 start-page: 246 year: 2015 end-page: 251 ident: bb0120 article-title: Predictive value of the age-adjusted Charlson comorbidity index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer publication-title: Gynecol Oncol – volume: 15 start-page: 1014 year: 2005 end-page: 1022 ident: bb0025 article-title: Prognostic factors in ovarian carcinoma stage III patients. Can biomarkers improve the prediction of short- and long-term survivors? publication-title: Int J Gynecol Cancer – volume: 147 start-page: 73 year: 2017 end-page: 80 ident: bb0095 article-title: Survival and safety associated with aggressive surgery for stage III/IV epithelial ovarian cancer: a single institution observation study publication-title: Gynecol Oncol – volume: 114 start-page: 26 year: 2009 end-page: 31 ident: bb0055 article-title: Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm publication-title: Gynecol Oncol – volume: 140 start-page: 42 year: 2016 end-page: 47 ident: bb0010 article-title: Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation status publication-title: Gynecol Oncol – volume: 14 start-page: 772 year: 2004 end-page: 778 ident: bb0015 article-title: Long-term survival in 463 women treated with platinum analogs for advanced epithelial carcinoma of the ovary: life expectancy compared to women of an age-matched normal population publication-title: Int J Gynecol Cancer – volume: 96 start-page: 889 year: 1989 end-page: 892 ident: bb0075 article-title: Revised FIGO staging for gynaecological cancer publication-title: Br J Obstet Gynaecol – volume: 199 start-page: 1 year: 2008 end-page: 6 ident: bb0080 article-title: Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma publication-title: Am J Obstet Gynecol – volume: 113 start-page: 775 year: 2009 end-page: 782 ident: bb0090 article-title: Results from four rounds of ovarian cancer screening in a randomized trial publication-title: Obstet Gynecol – volume: 363 start-page: 943 year: 2010 end-page: 953 ident: bb0060 article-title: Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer publication-title: N Engl J Med – volume: 107 start-page: 77 year: 2006 end-page: 85 ident: bb0035 article-title: Aggressive surgical effort and improved survival in advanced-stage ovarian cancer publication-title: Obstet Gynecol – volume: 26 start-page: 336 year: 2015 end-page: 342 ident: bb0045 article-title: Role of aggressive surgical cytoreduction in advanced ovarian cancer publication-title: J Gynecol Oncol – volume: 150 start-page: 446 year: 2018 end-page: 450 ident: bb0115 article-title: Interval between debulking surgery and adjuvant chemotherapy is associated with overall survival in patients with advanced ovarian cancer publication-title: Gynecol Oncol – volume: 140 start-page: 215 year: 2016 end-page: 220 ident: bb0040 article-title: Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IV publication-title: Gynecol Oncol – volume: 20 start-page: 1248 year: 2002 end-page: 1259 ident: bb0050 article-title: Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis publication-title: J Clin Oncol – volume: 386 start-page: 249 year: 2015 end-page: 257 ident: bb0065 article-title: Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial publication-title: Lancet – volume: 24 start-page: 3692 year: 2017 end-page: 3699 ident: bb0105 article-title: Prognostic value of the age-adjusted Charlson comorbidity index (ACCI) on short- and long-term outcome in patients with advanced primary epithelial ovarian Cancer publication-title: Ann Surg Oncol – volume: 197 start-page: 1 year: 2007 end-page: 7 ident: bb0110 article-title: Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer publication-title: Am J Obstet Gynecol – volume: 93 start-page: 21 year: 1999 end-page: 24 ident: bb0030 article-title: Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings publication-title: Obstet Gynecol – volume: 115 start-page: 1234 year: 2009 end-page: 1244 ident: bb0020 article-title: Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of prospectively randomized phase 3 multicenter trials publication-title: Cancer – volume: 32 start-page: 2026 year: 2018 end-page: 2037 ident: bb0070 article-title: Laparoscopy for primary cytoreduction with multivisceral resections in advanced ovarian cancer: prospective validation. "the times they are a-changin"? publication-title: Surg Endosc – volume: 149 start-page: 263 year: 2018 end-page: 269 ident: bb0100 article-title: Assessment of preoperative nutritional status using BIA-derived phase angle (PhA) in patients with advanced ovarian cancer: correlation with the extent of cytoreduction and complications publication-title: Gynecol Oncol – volume: 17 start-page: 1642 year: 2010 end-page: 1648 ident: bb0005 article-title: Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease publication-title: Ann Surg Oncol – volume: 140 start-page: 42 year: 2016 ident: 10.1016/j.sopen.2019.05.005_bb0010 article-title: Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation status publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2015.11.009 – volume: 140 start-page: 215 year: 2016 ident: 10.1016/j.sopen.2019.05.005_bb0040 article-title: Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IV publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2015.12.007 – volume: 197 start-page: 1 year: 2007 ident: 10.1016/j.sopen.2019.05.005_bb0110 article-title: Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2007.10.495 – volume: 32 start-page: 2026 year: 2018 ident: 10.1016/j.sopen.2019.05.005_bb0070 article-title: Laparoscopy for primary cytoreduction with multivisceral resections in advanced ovarian cancer: prospective validation. "the times they are a-changin"? publication-title: Surg Endosc doi: 10.1007/s00464-017-5899-9 – volume: 138 start-page: 246 year: 2015 ident: 10.1016/j.sopen.2019.05.005_bb0120 article-title: Predictive value of the age-adjusted Charlson comorbidity index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2015.05.034 – volume: 93 start-page: 21 year: 1999 ident: 10.1016/j.sopen.2019.05.005_bb0030 article-title: Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings publication-title: Obstet Gynecol – volume: 24 start-page: 3692 year: 2017 ident: 10.1016/j.sopen.2019.05.005_bb0105 article-title: Prognostic value of the age-adjusted Charlson comorbidity index (ACCI) on short- and long-term outcome in patients with advanced primary epithelial ovarian Cancer publication-title: Ann Surg Oncol doi: 10.1245/s10434-017-6079-9 – volume: 14 start-page: 772 year: 2004 ident: 10.1016/j.sopen.2019.05.005_bb0015 article-title: Long-term survival in 463 women treated with platinum analogs for advanced epithelial carcinoma of the ovary: life expectancy compared to women of an age-matched normal population publication-title: Int J Gynecol Cancer doi: 10.1136/ijgc-00009577-200409000-00006 – volume: 96 start-page: 889 year: 1989 ident: 10.1016/j.sopen.2019.05.005_bb0075 article-title: Revised FIGO staging for gynaecological cancer publication-title: Br J Obstet Gynaecol doi: 10.1111/j.1471-0528.1989.tb03341.x – volume: 107 start-page: 77 year: 2006 ident: 10.1016/j.sopen.2019.05.005_bb0035 article-title: Aggressive surgical effort and improved survival in advanced-stage ovarian cancer publication-title: Obstet Gynecol doi: 10.1097/01.AOG.0000192407.04428.bb – volume: 114 start-page: 26 year: 2009 ident: 10.1016/j.sopen.2019.05.005_bb0055 article-title: Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2009.03.018 – volume: 199 start-page: 1 year: 2008 ident: 10.1016/j.sopen.2019.05.005_bb0080 article-title: Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma publication-title: Am J Obstet Gynecol doi: 10.1016/j.ajog.2008.06.052 – volume: 363 start-page: 943 year: 2010 ident: 10.1016/j.sopen.2019.05.005_bb0060 article-title: Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa0908806 – volume: 17 start-page: 1642 year: 2010 ident: 10.1016/j.sopen.2019.05.005_bb0005 article-title: Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease publication-title: Ann Surg Oncol doi: 10.1245/s10434-010-0964-9 – volume: 386 start-page: 249 year: 2015 ident: 10.1016/j.sopen.2019.05.005_bb0065 article-title: Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial publication-title: Lancet doi: 10.1016/S0140-6736(14)62223-6 – volume: 250 start-page: 187 year: 2009 ident: 10.1016/j.sopen.2019.05.005_bb0085 article-title: The Clavien-Dindo classification of surgical complications: five-year experience publication-title: Ann Surg doi: 10.1097/SLA.0b013e3181b13ca2 – volume: 115 start-page: 1234 year: 2009 ident: 10.1016/j.sopen.2019.05.005_bb0020 article-title: Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of prospectively randomized phase 3 multicenter trials publication-title: Cancer doi: 10.1002/cncr.24149 – volume: 113 start-page: 775 year: 2009 ident: 10.1016/j.sopen.2019.05.005_bb0090 article-title: Results from four rounds of ovarian cancer screening in a randomized trial publication-title: Obstet Gynecol doi: 10.1097/AOG.0b013e31819cda77 – volume: 150 start-page: 446 year: 2018 ident: 10.1016/j.sopen.2019.05.005_bb0115 article-title: Interval between debulking surgery and adjuvant chemotherapy is associated with overall survival in patients with advanced ovarian cancer publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2018.07.004 – volume: 15 start-page: 1014 year: 2005 ident: 10.1016/j.sopen.2019.05.005_bb0025 article-title: Prognostic factors in ovarian carcinoma stage III patients. Can biomarkers improve the prediction of short- and long-term survivors? publication-title: Int J Gynecol Cancer doi: 10.1136/ijgc-00009577-200511000-00003 – volume: 26 start-page: 336 year: 2015 ident: 10.1016/j.sopen.2019.05.005_bb0045 article-title: Role of aggressive surgical cytoreduction in advanced ovarian cancer publication-title: J Gynecol Oncol doi: 10.3802/jgo.2015.26.4.336 – volume: 147 start-page: 73 year: 2017 ident: 10.1016/j.sopen.2019.05.005_bb0095 article-title: Survival and safety associated with aggressive surgery for stage III/IV epithelial ovarian cancer: a single institution observation study publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2017.07.136 – volume: 149 start-page: 263 year: 2018 ident: 10.1016/j.sopen.2019.05.005_bb0100 article-title: Assessment of preoperative nutritional status using BIA-derived phase angle (PhA) in patients with advanced ovarian cancer: correlation with the extent of cytoreduction and complications publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2018.03.044 – volume: 20 start-page: 1248 year: 2002 ident: 10.1016/j.sopen.2019.05.005_bb0050 article-title: Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis publication-title: J Clin Oncol doi: 10.1200/JCO.2002.20.5.1248 |
| SSID | ssj0002794034 |
| Score | 2.1665287 |
| Snippet | AbstractBackgroundTo evaluate the impact of extended surgical treatment performed by a team of gynecologists and general surgeons on postoperative morbidity... To evaluate the impact of extended surgical treatment performed by a team of gynecologists and general surgeons on postoperative morbidity and survival of... Background: To evaluate the impact of extended surgical treatment performed by a team of gynecologists and general surgeons on postoperative morbidity and... |
| SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 43 |
| SubjectTerms | Surgery |
| Title | Aggressive surgery for advanced ovarian cancer performed by a multidisciplinary team: A retrospective analysis on a large series of patients |
| URI | https://www.clinicalkey.es/playcontent/1-s2.0-S2589845019300120 https://dx.doi.org/10.1016/j.sopen.2019.05.005 https://www.ncbi.nlm.nih.gov/pubmed/32754692 https://www.proquest.com/docview/2430671053 https://pubmed.ncbi.nlm.nih.gov/PMC7391894 https://doaj.org/article/bde0baa4ef154d5aac1537d8e7e838a9 |
| Volume | 1 |
| WOSCitedRecordID | wos000693660100009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2589-8450 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002794034 issn: 2589-8450 databaseCode: DOA dateStart: 20190101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2589-8450 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002794034 issn: 2589-8450 databaseCode: M~E dateStart: 20190101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9UwEA-6ePAiil_1Y4ng0WI_kibx9pRdvLgIKrxbyKe-ZW2X9u2Cl_0L9o92Jm0ffQrrxUuhTQNJ5pfMDJn5DSGvQxENKyPPS2VizirwWQ0odrx9lM43SDFmU7EJcXIi12v1eVHqC2PCRnrgceHeWh8KawwLEZS958Y42KPCyyCCrKVJqXtg9SycqdN0naZYka6UKy5VLhkvZsqhFNw1YG0qDOxSibcTi9ct1FJi79_TTn9bn38GUS600vF9cm8yJ-lqnMYDciu0D8n16nvyouEgo8OY9kzBNqXzfT_tLsFDNi11-NrT8zF5ABrsL2poijFcZutSAMLPd3RF-7Dtuzk3k5qJz4R2LfQ6w5ByioAO8CXSibB1eES-HR99_fAxn6ou5I7LYpszJ1RhQUsZEGOtwJ7ypRFN5L6OvBTQ0ijJZVDOg_EBQPS89rZk0YArY3ysH5ODtmvDU0IbGyvBObdOGRZDtIKXNqIHWFo4oF1GqnnRtZsoybEyxpmeY89OdZKURknpgmuQVEbe7Dqdj4wcN__-HqW5-xXptNMHAJmeQKb_BbKMiBkLes5YhTM2DNOGH3Sph0oX-gvCDdEGdnHKS85Is-s52TSjrQKD2Nw87lcz5jTseLzGMW3oLgZdMXTzwC6uM_JkxOBudjWsN2tUBQPeQ-fe9Pdb2s2PxCouQNZSsWf_Y72ek7s4lTGs-QU52PYX4SW54y63m6E_JLfFWh6mDQvPT1dHvwFwekoh |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Aggressive+surgery+for+advanced+ovarian+cancer+performed+by+a+multidisciplinary+team%3A+A+retrospective+analysis+on+a+large+series+of+patients&rft.jtitle=Surgery+open+science&rft.au=Rausei%2C+Stefano&rft.au=Uccella%2C+Stefano&rft.au=D%27Alessandro%2C+Valentina&rft.au=Gisone%2C+Baldo&rft.date=2019-07-01&rft.issn=2589-8450&rft.eissn=2589-8450&rft.volume=1&rft.issue=1&rft.spage=43&rft.epage=47&rft_id=info:doi/10.1016%2Fj.sopen.2019.05.005&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_sopen_2019_05_005 |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F25898450%2FS2589845019X00020%2Fcov150h.gif |